Relationship between clinical and patient-reported outcomes in a phase 3 trial of tofacitinib or MTX in MTX-naïve patients with rheumatoid arthritis

OBJECTIVE: To compare the relationship between clinical measures and patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) treated with tofacitinib or methotrexate (MTX). METHODS: In a phase 3 randomised controlled trial, patients (N=956) who were MTX-naïve or had received ≤3 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Roy, Strand, Vibeke, Wilkinson, Bethanie, Kwok, Kenneth, Bananis, Eustratios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860866/
https://www.ncbi.nlm.nih.gov/pubmed/27175296
http://dx.doi.org/10.1136/rmdopen-2015-000232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860866/
https://www.ncbi.nlm.nih.gov/pubmed/27175296
http://dx.doi.org/10.1136/rmdopen-2015-000232

Ejemplares similares